General MedicationsINJECTIONGeneric
YUTOPAR
RITODRINE HYDROCHLORIDE
Standard Dose
10MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview YUTOPAR is listed in Drugs@FDA under application 018580 (NDA).
Marketing status: Discontinued Active ingredient RITODRINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 10MG/ML Sponsor ASTRAZENECA Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview YUTOPAR is listed in Drugs@FDA under application 018580 (NDA). Marketing status: Discontinued Active ingredient RITODRINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 10MG/ML Sponsor ASTRAZENECA Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.